Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.18 is 23% below its 5-year average of 0.23, near the low end of its 5-year range (0.00–22.41).
As of the fiscal period ended Wednesday, December 31, 2025. 4.01% below its 12-month average of 0.19.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 0.18.
QUICK RATIO (ACID-TEST)
0.18
QUICK RATIO (ACID-TEST) AVG TTM
0.19
QUICK RATIO (ACID-TEST) AVG 3Y
0.15
QUICK RATIO (ACID-TEST) AVG 5Y
0.23
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-4.01%
CURRENT VS 3Y AVG
+15.06%
CURRENT VS 5Y AVG
-23.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 563 covered companies
CURRENT VS SECTOR MEDIAN
-94.06%
vs the sector median at left
EUDA Health Holdings Limited
Market Cap
$32.31M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.19
3Y Avg
0.15
5Y Avg
0.23
Market Cap
$32.34M
Quick Ratio (Acid-Test)
5.81
TTM Avg
22.07
3Y Avg
14.94
5Y Avg
12.78
Market Cap
$32.55M
Quick Ratio (Acid-Test)
2.19
TTM Avg
3.38
3Y Avg
4.17
5Y Avg
5.03
Market Cap
$31.52M
Quick Ratio (Acid-Test)
200.08
TTM Avg
9.87
3Y Avg
7.20
5Y Avg
5.25
Market Cap
$31.46M
Quick Ratio (Acid-Test)
0.70
TTM Avg
2.07
3Y Avg
2.92
5Y Avg
4.15
Market Cap
$33.32M
Quick Ratio (Acid-Test)
3.61
TTM Avg
1.56
3Y Avg
4.91
5Y Avg
7.24
Market Cap
$31.23M
Quick Ratio (Acid-Test)
1.26
TTM Avg
1.70
3Y Avg
1.87
5Y Avg
1.80
Market Cap
$30.86M
Quick Ratio (Acid-Test)
0.98
TTM Avg
1.21
3Y Avg
1.42
5Y Avg
1.87
Market Cap
$34.44M
Quick Ratio (Acid-Test)
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EUDA Health Holdings Limited (EUDA) | $32.31M | 0.18 | 0.19 | 0.15 | 0.23 |
| Context Therapeutics Inc. (CNTX)vs › | $32.34M | 5.81 | 22.07 | 14.94 | 12.78 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.55M | 2.19 | 3.38 | 4.17 | 5.03 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.52M | 200.08 | 9.87 | 7.20 | 5.25 |
| BeyondSpring Inc. (BYSI)vs › | $31.46M | 0.70 | 2.07 | 2.92 | 4.15 |
| HeartBeam, Inc. (BEAT)vs › | $33.32M | 3.61 | 1.56 | 4.91 | 7.24 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.23M | 1.26 | 1.70 | 1.87 | 1.80 |
| MDxHealth S.A. (MDXH)vs › | $30.86M | 0.98 | 1.21 | 1.42 | 1.87 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.44M | 11.47 | 9.93 | 10.68 | 16.03 |
| CervoMed Inc. (CRVO)vs › | $30.00M | 8.57 | 7.97 | 5.03 | 6.79 |
Quick Ratio
0.18
Excludes inventory
Current Ratio
0.18
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 0.18 |
| 2025-09-30 | 0.18 |
| 2025-06-30 | 0.21 |
| 2025-03-31 | 0.21 |
| 2024-12-31 | 0.15 |
| 2024-09-30 | 0.15 |
| 2024-06-30 | 0.13 |
| 2024-03-31 | 0.13 |
| 2023-12-31 | 0.08 |
| 2023-09-30 | 0.08 |
| 2023-06-30 | 0.19 |
| 2023-03-31 | 0.79 |
| 2022-12-31 | 0.84 |
| 2022-10-31 | 17.38 |
| 2022-06-30 | 19.15 |
| 2022-03-31 | 22.41 |
| 2021-12-31 | 0.59 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
